Today we are participating in the government’s visit to Biosurfit, in Azambuja.

Focused on the development and manufacture of IVD (in vitro diagnostics) tests at the Point-of-Care with highly innovative technology and with about 100 qualified workers, Biosurfit was the first Portugal based startup to benefit from the 200M Fund investment.

In a partnership with Boule Diagnostics investing EUR 5 million and another EUR 5 million invested by 200M, Biosurfit raised a total of EUR 10 million in capital to support the growth of the current business into different worldwide markets and to continuously research and develop new products.

 

 

 

Share This Post: